Dichloromethane fraction of Moringa oleifera leaf methanolic extract selectively inhibits breast cancer cells (MCF7) by induction of apoptosis via upregulation of Bax, p53 and caspase 8 expressions
- PMID: 34086162
- DOI: 10.1007/s11033-021-06466-y
Dichloromethane fraction of Moringa oleifera leaf methanolic extract selectively inhibits breast cancer cells (MCF7) by induction of apoptosis via upregulation of Bax, p53 and caspase 8 expressions
Abstract
Moringa oleifera is a well-known medicinal plant which has anti-cancer and other biological activities. This research aims to determine the cytotoxic and apoptotic effect of M. oleifera leave extract on the breast cancer (MCF7) cells. The extracts were prepared using hexane, dichloromethane, chloroform and n-butanol by fractionating the crude 80% methanol extract of the plant leaves. The cytotoxic effect of the extracts on MCF7 cells were determined using CellTiter 96® AQueous One Solution Cell Proliferation (MTS) assay. The apoptosis study was conducted using Annexin V-FITC analysis and confirmed by Western blotting using selected proteins, which are p53, Bax, cytochrome c and caspase 8. Our results showed that the dichloromethane (DF-CME-MOL) extract was selectively cytotoxic to MCF7 cells (5 μg/mL) without significantly inhibiting the non-cancerous breast (MCF 10A) cells. It had the highest selectivity index (SI) value of 9.5 among the tested extracts. It also induced early apoptosis and increased the expressions of pro-apoptotic proteins Bax, caspase 8 and p53 in MCF7 cells. Gas chromatography-mass spectrometry analysis (GC-MS) analysis showed that the major compounds found in DF-CME-MOL were benzeneacetonitrile, 4-hydroxy- and benzeneacetic acid, 4-hydroxy-, methyl ester among others that were detected. Thus, DF-CME-MOL extract was found to inhibit the proliferation of MCF7 cells by apoptosis induction, which is likely due to the activities of the detected phytochemical compounds of the extract.
Keywords: Apoptosis; Bax; Caspase 8; Cytotoxicity; MCF 10A; MCF7 cells; Moringa oleifera; p53.
References
-
- Abd Rani NZ, Husain K, Kumolosasi E (2018) Moringa genus: a review of phytochemistry and pharmacology. Front Pharmacol 9:1–26. https://doi.org/10.3389/fphar.2018.00108 - DOI
-
- Leone A, Spada A, Battezzati A et al (2015) Cultivation, genetic, ethnopharmacology, phytochemistry and pharmacology of Moringa oleifera leaves: an overview. Int J Mol Sci 16:12791–12835. https://doi.org/10.3390/ijms160612791 - DOI - PubMed - PMC
-
- Do BH, Nguyen TPT, Ho NQC et al (2020) Mitochondria-mediated Caspase-dependent and Caspase-independent apoptosis induced by aqueous extract from Moringa oleifera leaves in human melanoma cells. Mol Biol Rep 47:3675–3689. https://doi.org/10.1007/s11033-020-05462-y - DOI - PubMed
-
- Adebayo IA, Arsad H, Samian MR (2017) Antiproliferative effect on breast cancer (MCF7) of Moringa oleifera seed extracts. Afr J Tradit Complement Altern Med 14:282–287. https://doi.org/10.21010/ajtcam.v14i2.30 - DOI - PubMed - PMC
-
- Al-Asmari AK, Albalawi SM, Athar MT et al (2015) Moringa oleifera as an anti-cancer agent against breast and colorectal cancer cell lines. PLoS ONE 10:1–14. https://doi.org/10.1371/journal.pone.0135814 - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
